Akarsu, OzgerBaysal, OrhanKaradag, SerhatGursu, MeltemOzkan, OktayUzun, SamiGurdal, AhmetCebeci, EgemenSumnu, AbdullahBehlul, AhmetOzturk, Savas2021-01-282021-01-282020-10-01Akarsu O., Baysal O., Karadag S., Gursu M., Ozkan O., Uzun S., Gurdal A., Cebeci E., Sumnu A., Behlul A., et al., -Cardiometabolic Role of Visfatin in Patients on Peritoneal Dialysis-, TURKISH JOURNAL OF NEPHROLOGY, cilt.29, ss.297-303, 2020http://hdl.handle.net/20.500.12645/28201Objective: There is a relationship between inflammation and cardiovascular disease (CVD) in patients with chronic kidney disease. Visfatin is an adipocytokine, which has been shown to be associated with inflammation, endothelial dysfunction, and CVD. Our study aimed to examine the relationship of visfatin with metabolic and echocardiographic parameters in patients on peritoneal dialysis (PD).ArticleWOS:0005819477000078509587653010.5152/turkjnephrol.2020.4123